Document is current
Any future updates will be listed below
-
Authors
Chen, Li-Fen
Lin, Ching-En
Chung, Chi-Hsiang
Chung, Yong-An
Park, Sonya Youngju
Chang, Wei-Chou
Chang, Chuan-Chia
Chang, Hsin-An https://orcid.org/0000-0001-5572-7109
-
Funding
Funding for this research was provided by:
National Science and Technology Council (NSTC-112-2314-B-016-017-MY3)
Tri-Service General Hospital (TSGH_A_113015)
- License Information
-
More Information
Article History
Received: 7 September 2024
Accepted: 11 April 2025
First Online: 23 April 2025
Declarations
:
: During the last 5 years, Hsin-An Chang has received fees for presentations at congresses or advisory activities from Chen Hua Biotech, Eisai, Janssen, Lundbeck, Lotus, Otsuka, Pfizer, Servier, Sanofi-Aventis, Sumitomo Dainippon Pharma, Viatris. Li-Fen Chen, Ching-En Lin, Chi-Hsiang Chung, Yong-An Chung, Sonya Youngju Park, and Wei-Chou Chang declared no conflict of interest.
